Samotolisib, CAS [[1386874-06-1]]
Artikelnummer:
TGM-T6883
- Bilder (1)
| Artikelname: | Samotolisib, CAS [[1386874-06-1]] |
| Artikelnummer: | TGM-T6883 |
| Hersteller Artikelnummer: | T6883 |
| Alternativnummer: | TGM-T6883-1MLX10MM(INDMSO),TGM-T6883-5MG,TGM-T6883-10MG,TGM-T6883-25MG,TGM-T6883-50MG,TGM-T6883-100MG,TGM-T6883-200MG |
| Hersteller: | TargetMol |
| Kategorie: | Biochemikalien |
| Alternative Synonym: | GTPL8918 , LY3023414 |
| Samotolisib (LY3023414) is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. Samotolisib (LY3023414) has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others. |
| Molekulargewicht: | 406.48 |
| Reinheit: | 99.71% |
| CAS Nummer: | [1386874-06-1] |
| Formel: | C23H26N4O3 |
| Target-Kategorie: | mTOR|||Autophagy|||DNA-PK|||PI3K |

